Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer.
Xu S, Liu D, Qin Z, Liang Z, Xie H, Yi B, Wang K, Lin G, Liu R, Yang K, et al. Aging (Albany NY). 2023 Dec 21; 15(24):15134-15160. Epub 2023 Dec 21.